2A41ICD-11 MMS 2026-01
Atypical chronic myeloid leukaemia, BCR-ABL1-negative
Description
A myelodysplastic/myeloproliferative neoplasm characterised by the principal involvement of the neutrophil series with leukocytosis with circulating immature myeloid cells, fewer than 20 percent blasts in the bone marrow and blood, and severe dysgranulopoiesis. The neoplastic cells do not have a Philadelphia chromosome or the BCR/ABL1 fusion gene.
Index terms
- Atypical chronic myeloid leukaemia, BCR-ABL1-negative
- Atypical chronic myeloid leukaemia, BCR-ABL-negative without mention of remission
- atypical chronic myeloid leukaemia
Show allHide
- subacute monocytic leukaemia
- subacute monocytic leukaemia without mention of remission
- subacute myelogenous leukaemia
- subacute myeloid leukaemia
- subacute myelosis
- Atypical chronic myeloid leukaemia, BCR-ABL1-negative in complete remission
Exclusions from above levels
2E03– Malignant neoplasm metastasis in bone or bone marrow- http://id.who.int/icd/entity/501778925 – Malignant neoplasm metastasis in lymph nodes
- http://id.who.int/icd/entity/97145147 – Malignant neoplasm metastasis in thymus gland
Sibling codes
2A40– Chronic myelomonocytic leukaemia2A42– Juvenile myelomonocytic leukaemia2A43– Refractory anaemia with ring sideroblasts associated with marked thrombocytosis2A44– Myeloproliferative and myelodysplastic disease, unclassifiable2A4Y– Other specified myelodysplastic and myeloproliferative neoplasms2A4Z– Myelodysplastic and myeloproliferative neoplasms, unspecified
Foundation entity
Atypical chronic myeloid leukaemia, BCR-ABL1-negative – http://id.who.int/icd/entity/331838766
Allowed postcoordination axes
Part of: 02: Neoplasms